DERM

Journey Medical (DERM)

Journey Medical Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DERM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/07	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024	NASDAQ:DERM	Journey Medical Corporation
2024/05/02	05:01	GlobeNewswire Inc.	Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer	NASDAQ:DERM	Journey Medical Corporation
2024/04/25	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024	NASDAQ:DERM	Journey Medical Corporation
2024/03/22	05:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:DERM	Journey Medical Corporation
2024/03/18	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	NASDAQ:DERM	Journey Medical Corporation
2024/03/15	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024	NASDAQ:DERM	Journey Medical Corporation
2024/03/13	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the 36th Annual ROTH Conference	NASDAQ:DERM	Journey Medical Corporation
2024/03/11	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting	NASDAQ:DERM	Journey Medical Corporation
2024/02/24	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DERM	Journey Medical Corporation
2024/01/05	22:30	GlobeNewswire Inc.	Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	NASDAQ:DERM	Journey Medical Corporation
2024/01/03	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2024/01/03	06:05	GlobeNewswire Inc.	Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million	NASDAQ:DERM	Journey Medical Corporation
2023/12/16	06:46	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DERM	Journey Medical Corporation
2023/12/09	07:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/12/06	22:00	GlobeNewswire Inc.	Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea	NASDAQ:DERM	Journey Medical Corporation
2023/11/08	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/11/08	06:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:DERM	Journey Medical Corporation
2023/10/31	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023	NASDAQ:DERM	Journey Medical Corporation
2023/10/20	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)	NASDAQ:DERM	Journey Medical Corporation
2023/10/18	05:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DERM	Journey Medical Corporation
2023/09/26	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/09/20	05:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/09/09	02:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DERM	Journey Medical Corporation
2023/09/06	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/09/06	21:00	GlobeNewswire Inc.	Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations	NASDAQ:DERM	Journey Medical Corporation
2023/08/19	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/08/15	05:01	GlobeNewswire Inc.	Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:DERM	Journey Medical Corporation
2023/08/11	05:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DERM	Journey Medical Corporation
2023/08/09	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DERM	Journey Medical Corporation
2023/08/09	05:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:DERM	Journey Medical Corporation